Tessenderlo Group NV (LON:0KCP)
25.73
-0.27 (-1.06%)
At close: Nov 7, 2025
Tessenderlo Group NV Revenue
Tessenderlo Group NV had revenue of 1.49B EUR in the half year ending June 30, 2025, a decrease of -8.55%. This brings the company's revenue in the last twelve months to 2.75B, up 2.05% year-over-year. In the year 2024, Tessenderlo Group NV had annual revenue of 2.65B, down -9.58%.
Revenue (ttm)
2.75B EUR
Revenue Growth
+2.05%
P/S Ratio
0.57
Revenue / Employee
369.68K EUR
Employees
7,428
Market Cap
1.35B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.65B | -280.60M | -9.58% |
| Dec 31, 2023 | 2.93B | 340.80M | 13.17% |
| Dec 31, 2022 | 2.59B | 506.00M | 24.31% |
| Dec 31, 2021 | 2.08B | 344.20M | 19.81% |
| Dec 31, 2020 | 1.74B | -5.60M | -0.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |